Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Aion Therapeutic's share price for the quarter that ended in Oct. 2024 was $0.0058. Aion Therapeutic's Shares Outstanding (EOP) for the quarter that ended in Oct. 2024 was 497.15 Mil. Therefore, Aion Therapeutic's market cap for the quarter that ended in Oct. 2024 was $2.88 Mil.
Aion Therapeutic's quarterly market cap
increased
from Apr. 2024 ($2.47 Mil) to Jul. 2024 ($3.14 Mil) but then
declined
from Jul. 2024 ($3.14 Mil) to Oct. 2024 ($2.88 Mil).
Aion Therapeutic's annual market cap
declined
from Apr. 2022 ($1.57 Mil) to Apr. 2023 ($0.53 Mil) but then
increased
from Apr. 2023 ($0.53 Mil) to Apr. 2024 ($2.47 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Aion Therapeutic's Enterprise Value for Today is $5.09 Mil.
Aion Therapeutic Market Cap Historical Data
The historical data trend for Aion Therapeutic's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Aion Therapeutic's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Aion Therapeutic's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aion Therapeutic's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aion Therapeutic's Market Cap distribution charts can be found below:
* The bar in red indicates where Aion Therapeutic's Market Cap falls into.
Aion Therapeutic Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Aion Therapeutic's Market Cap for the fiscal year that ended in Apr. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aion Therapeutic (OTCPK:ANTCF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Aion Therapeutic Market Cap Related Terms
Thank you for viewing the detailed overview of Aion Therapeutic's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery. During the year ended the Company had one operating segment, being health and wellness, dedicated to delivering state-of-the-art water filtration solutions. Geographically company earns revenue from USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ANTCF has been successfully added to your 